British Journal of Ophthalmology · 1992 · 61 citations · 6 references
MedicineOphthalmologyPharmacologyClinical PharmacologyOcular DiseaseOcular PharmacologyOcular PharmacodynamicsTopical Ocular Drug DeliveryTopical Ophthalmic MedicationsForeign Body Sensation ManagementIntraocular Pressure ElevationIntraocular Pressure ManagementIntraocular Pressure ReductionIntravitreal Foreign BodyOcular Hypertension TreatmentProstaglandin Analog TherapyTopical Ocular Pharmacodynamics
PhXA34, a prostaglandin analogue, was given topically to 40 patients with untreated ocular hypertension in a double masked randomised study. One single dose of 0.3, 1, 3, 10 micrograms, or placebo (vehicle) was given to one eye of each patient. A dose related IOP reduction ranging from 11 to 35% was observed with a maximal effect with 3 and 10 micrograms PhXA34. No hyperaemia was seen except after 10 micrograms PhXA34, where a mild to moderate hyperaemia was seen from 8 hours with a duration of up to 24 hours. Mild foreign body sensation in the PhXA34-treated eye was noted by three patients. No cells or flare were seen.
6
PhXA34, a New Potent Ocular Hypotensive Drug
Albert Alm · Archives of Ophthalmology · 1991 · 113 citations
Carl B. Camras, Earlene C. Siebold, Jacqueline S. Lustgarten et al. · Ophthalmology · 1989 · 105 citations